XJ-13 is a modern hybrid-sativa derived from Jack Herer genetics. Reportedly developed within the California medical cannabis community, the strain is widely credited to cultivators seeking to isolate specific uplifting traits from its influential parentage. Suited for both indoor and outdoor cultivation, the strain exhibits a moderate difficulty level and reaches maturity with a 66-day flowering cycle, ultimately rewarding growers with a high yield.

The chemical profile of XJ-13 is defined by a complex terpene hierarchy led by terpinolene, followed by caryophyllene, beta-pinene, myrcene, linalool, pinene, humulene, and limonene. This aromatic foundation is rounded out by the specific order of these compounds. This combination of compounds creates a distinct sensory experience that reflects the strain's dominant terpene, terpinolene, and the structural influence of the secondary and tertiary contributors in the profile.

As a THC-dominant cultivar with 18.3% THC and 0% CBD, XJ-13 is largely utilized for its capacity to promote creativity, uplifted moods, and happiness. These effects make it a functional selection for tasks requiring sustained focus or for facilitating social engagement. The genetic legacy of XJ-13 is further evidenced by its role as a parent for several offspring, including Dave's Blueberry XJ, Dave's Bubblelicious XJ, and Dave's Grape XJ.